Showing results (141-150 of 164) with videos related to
Sort By:
Pageof 17
Journal of the National Cancer Institute. Monographs|June 26, 2024
Telehealth Research and Innovation for Veterans with Cancer: the THRIVE CenterLeah L Zullig, Danil Makarov, Daniel Becker, et al.Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
VHA Practice Guideline Recommendations for Diffuse GliomasScott Kulich, Daniel Becker, Sanja Dacic, et al.Pharmaceutical Research|September 9, 2010
Pulmonary gene silencing in transgenic EGFP mice using aerosolised chitosan/siRNA nanoparticlesEbbe J B Nielsen, Jan M Nielsen, Daniel Becker, et al.Journal of Cardiovascular Electrophysiology|November 14, 2006
Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithmGeorge J Klein, Jeffrey M Gillberg, Anthony Tang, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 1, 2026
A Multicentre Observational Cohort Study to Compare Short Term and Midterm Outcomes after Fenestrated Endovascular Aortic Repair and Open Surgical Repair in Juxtarenal and Pararenal Aortic Aneurysm: The FEORA StudyDaniel Becker, Carlota Fernandes Prendes, Michel Joseph Bosiers, et al.Journal of Neurosurgery|August 27, 2005
Multi-germ layer lineage central nervous system repair: nerve and vascular cell generation by embryonic stem cells transplanted in the injured brainSudhakar Vadivelu, Marina M Platik, Luke Choi, et al.Plos One|February 28, 2019
Correction: Contribution of the Cpx envelope stress system to metabolism and virulence regulation in Salmonella enterica serovar TyphimuriumSivaraman Subramaniam, Volker S Müller, Nina A Hering, et al.Plos One|February 5, 2019
Contribution of the Cpx envelope stress system to metabolism and virulence regulation in Salmonella enterica serovar TyphimuriumSivaraman Subramaniam, Volker S Müller, Nina A Hering, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancerBenjamin Levy, Alexander Spira, Daniel Becker, et al.JCO Oncology Practice|January 17, 2023
Veterans Health Administration National TeleOncology ServiceLeah L Zullig, Whitney Raska, Gina McWhirter, et al.Pageof 17